Despite IV Vancomycin’s Stronghold on the MRSA Antibiotic Hospital Market, Surveyed ID Specialists Report Shifting Away from IV Vancomycin to Branded Agents, Including Pfizer’s Zyvox and Cubist/ ...

TMP-SMX is a viable initial antibiotic for CA-MRSA infection, as many, but not all, ... Linezolid is available in an oral liquid formulation and intravenous formulation.

A new, single-dose antibiotic may be as effective as traditional treatment against methicillin-resistant Staphylococcus aureus (MRSA), a dangerous strain of antibiotic-resistant bacteria. In a new ...

Oral or IV Antibiotics for Children With Osteomyelitis? - Medscape - May 04, 2015. Tables. References. Authors and Disclosures. ... MRSA Rising in Children With Musculoskeletal Infections; b ...

If oral antibiotics are not effective, or MRSA has entered the bloodstream or infected other organs or tissues, doctors may recommend intravenous (IV) antibiotics.

“The safety and efficacy of intravenous daptomycin was comparable to standard-of-care IV antibiotics used for hospitalized children, usually vancomycin or clindamycin for MRSA and cefazolin for ...

Two of six patients with MRSA who switched to oral treatment died within 90 days versus two of 10 in the IV group with MRSA, they noted. SABATO ... After 5 to 7 days of IV antibiotic ...

New Antibiotic Approved for Skin Infections, Including MRSA. May 27, 2014 ... Dalvance is the first intravenous antibiotic approved for the treatment of ABSSI with a 2-dose regimen.

MRSA skin infections are often treated with intravenous injection of antibiotics, which can cause significant side effects and promote the development of resistant bacterial strains. To solve ...

Our study, involving 61 immunocompentent patients with primary vertebral osteomyelitis, illustrates that switching to an oral antibiotic regimen after 2 weeks of intravenous therapy may be safe ...